EFTA00658582
ity. As per the Operating Agreement, the Company will be led by a Board of Directors, whose directives shall be implemented by a Manager, currently David Levy. The Manager serves at the will of the Board and will be paid a management fee of $10,000 quarterly for year one and up to $40,0 0 0 quarterly for
EFTA00805860
N 29 EFTA00805888 illyto[6ffniqz Investment Report: October 23, 2017 OH2 Laboratories, LLC 132 Oxford St., Ste I A Cambridge, MA 02140 CEO: David Levy Website: http://www.oh2laboratories.com/ Investment: No. of Shares Investment Date Description Amount Invested Value Value Methodology -
EFTA00866712
the COI risk has been well-addressed and can permit this investment to go forward. Thank you for your consideration and assistance. Kind regards, David Levy, '92, SM '87, SB '87 please note The information contained in this communication is confidential, may be attorney-client privileged, may constit
EFTA00689370
g units to third parties by Unit holders. Not sure if Joi has any Board representation. The initial Board of Managers consists of: > Ayaz Mahmud > David Levy > Mark Rioult > Jean-Marie Vallet and > Steve Yang, > DARREN K. INDYKE > DARREN K. INDYKE, PLLC > 575 Lexington Avenue, 4th Floor EFTA00689370
EFTA00635610
s — as estimated by Kantrowitz — that four-year price tag suddenly balloons to nearly $108,000. "The parents are probably the most surprised," said David Levy, editor of Edvisors, a website that assists families in planning and paying for college. "Students often have no idea how expensive it is because M
EFTA00513222
Users,(Deleted)/Library/MailN2/Maceent Messages.mbox/5184DD6D-098A -4810-977E-8613A4F7EC65/Data/3/9/Messages/93533.emix SourceType Mac Mail First David Levy Email (Email) ID 1073632 Contact Source Device NYCO24329.aff4/Macintosh HD Path /Users/Icaryna/Library/MailN6/1B90A3EB-0561-4DB6-A847-27A65
EFTA00586577
OH2 Laboratories Re-engineering Drug Discovery Company Overview February 2015 David Levy, Ph.D. General Manager and Chairman OH2 Laboratories, LLC Confidential and Proprietary EFTA00586577 Introductions: The OH2 Laboratories Team
EFTA02716629
I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma
EFTA02594854
regated proteins.4, EFTA_R1_01779011 EFTA02594854 I am very pleased that you are very interested in taking a su=-licensing of our invention. Dr. David Levy, the Managing Director o= OH2Laboratories and Dr. Marc Rioult, former MIT TLO Senior Officer will t=ke lead on the negotiation. They are very exper
EFTA02338495
I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma
EFTA02355504
I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma
EFTA02513454
OI risk has been well-addressed and can permit this investment to go for=ard. Thank you for your consideration and assistance. Kind regards, =br> David Levy, Ph.D. '92, SM '=7, SB '87 2 EFTA_R1_01646626 EFTA02513455 4> please note The information contained in this communicati=n is confidential, ma
EFTA02513562
I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma
HOUSE_OVERSIGHT_011472_sub_004 - HOUSE_OVERSIGHT_011871
/ BARAK / 15 By November, even his Foreign Minister, David Levy, was making noises about quitting. He said it would be a waste of time to stay in the cabinet if it was going to bring the peace process to a halt. I
HOUSE_OVERSIGHT_027849_sub_004 - HOUSE_OVERSIGHT_028248
/ BARAK / 15 By November, even his Foreign Minister, David Levy, was making noises about quitting. He said it would be a waste of time to stay in the cabinet if it was going to bring the peace process to a halt. I

Joi Ito
PersonJapanese-American activist, entrepreneur, and venture capitalist

Jeffrey Epstein
PersonAmerican sex offender and financier (1953–2019)
Kyara Investments
OrganizationOrganization referenced in documents

George W. Bush
PersonPresident of the United States from 2001 to 2009

United States
LocationCountry located primarily in North America

Bill Clinton
PersonPresident of the United States from 1993 to 2001 (born 1946)

Barack Obama
PersonPresident of the United States from 2009 to 2017

Michael Cohen
PersonAmerican former attorney and former Republican official
Shuguang
PersonName reference in documents

South
LocationDirectional region of the United States

Virginia Giuffre
PersonAdvocate for sex trafficking victims (1983–2025)

Shimon Peres
PersonIsraeli politician (1923–2016) –Former President of Israel (2007–2014) and Prime Minister of Israel (1977, 1984–1986, 1995–1996)

Entebbe
LocationLocation referenced in documents

Johannesburg
LocationLargest city in South Africa

Norway
LocationCountry in Northern Europe

Geneva
LocationCity in Switzerland and capital of its canton

Kofi Annan
Person7th Secretary-General of the United Nations (1938-2018)

Chris Christie
Person55th Governor of New Jersey and former U.S. Attorney for the District of New Jersey
Sharon
PersonAmbiguous first name - refers to multiple Sharons including Ariel Sharon, Sharon Churcher, and Mishmar Hasharon location

Peter Mandelson
PersonBritish politician and life peer (born 1953)